| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 7,367.46 | 31.44 | -697.80 | 622.41 |
| Net Changein Cash | 21.87 | 77.19 | 21.76 | 155.73 |
| Cash Taxes Paid | 566.75 | 479.53 | 323.10 | 499.51 |
| Net Income/ Starting Line | 2,516.33 | 2,399.36 | 1,671.24 | 1,974.60 |
| Changesin Working Capital | -646.20 | -459.12 | -156.37 | -1,085.63 |
| Cashfrom Operating Activities | 2,470.95 | 2,152.45 | 1,813.30 | 919.78 |
| Cash Interest Paid | 98.13 | 26.17 | 41.93 | 17.79 |
| Cashfrom Financing Activities | 10,232.56 | 5.27 | -739.73 | 604.62 |
| Issuance( Retirement)of Stock Net | 2,963.23 | - | - | - |
| Depreciation/ Depletion | 621.22 | 398.25 | 325.92 | 166.62 |
| Other Investing Cash Flow Items Total | -12,152.19 | -1,692.48 | -222.06 | 976.38 |
| Capital Expenditures | -530.76 | -389.21 | -832.07 | -2,345.52 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 1.31 | 1.17 | 2.32 | 0.48 |
| Non- Cash Items | -20.40 | -186.05 | -27.49 | -135.81 |
| Financing Cash Flow Items | -98.13 | -26.17 | -41.93 | -17.79 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -12,682.95 | -2,081.69 | -1,054.13 | -1,369.14 |
Mankind Pharma Dividend Mankind Pharma Bonus Mankind Pharma News Mankind Pharma AGM Mankind Pharma Rights Mankind Pharma Splits Mankind Pharma Board Meetings Mankind Pharma Key Metrics Mankind Pharma Shareholdings Mankind Pharma Profit Loss Mankind Pharma Balance Sheet Mankind Pharma Q1 Results Mankind Pharma Q2 Results Mankind Pharma Q3 Results Mankind Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks